Dan Maller
Head of Investor Relations, B1 Medicines
Replay available
BeOne Medicines Ltd. (ONC) Q1 2026 Earnings Call
BeOne Medicines Ltd. (NASDAQ: ONC) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Euler
Co-founder, Chairman and Chief Executive Officer, B1 Medicines
Aaron Rosenberg
Chief Financial Officer, B1 Medicines
Lai Wang
President and Global Head of Research and Development, B1 Medicines
Amit Agarwal
Chief Medical Officer, Hematology, B1 Medicines
Matt Shaulis
General Manager of North America, B1 Medicines
Xiaobin Wu
President and Chief Operating Officer, B1 Medicines
Mark Lanassa
Chief Medical Officer, Solid Tumors, B1 Medicines
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Beone Medicines Ltd. Class A.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.382 Good day, everyone. Welcome to B1 Medicine's Q1 2026 earnings 00:00:05.382 -- 00:00:10.432 call webcast. All lines have been placed on mute to prevent any background noise. 00:00:10.432 -- 00:00:13.719 After the speaker's remarks, there will be a question and answer session. 00:00:13.719 -- 00:00:18.926 At this time, I would like to turn the call over to the company. 00:00:19.876 -- 00:00:22.282 Hello and welcome. Thanks for joining us today. 00:00:22.282 -- 00:00:25.911 I'm Dan Maller, Head of Investor Relations at B1 Medicines. 00:00:25.911 -- 00:00:30.142 Before we begin, please note that you can find additional materials, including a replay 00:00:30.142 -- 00:00:34.914 of today's webcast and presentation on the Investor Relations section of our website, 00:00:34.914 -- 00:00:36.914 ir.b1medicines.com. 00:00:38.320 -- 00:00:41.886 I would like to remind all participants that during this call, we may make forward-looking 00:00:41.886 -- 00:00:45.793 statements regarding, among other things, the company's future prospects and business 00:00:45.793 -- 00:00:51.123 strategy. Actual results may differ materially from those indicated in the forward-looking 00:00:51.123 -- 00:00:55.811 statements as a result of various factors, including those risks discussed in our most 00:00:55.811 -- 00:00:59.600 recent periodic report filed with the SEC. 00:00:59.600 -- 00:01:03.226 Please also carefully review the forward-looking statements disclaimer in the slide deck 00:01:03.226 -- 00:01:05.430 that accompanies this presentation. 00:01:05.430 -- 00:01:09.957 Reconciliations between GAAP and non-GAAP financial measures discussed on this call are 00:01:09.957 -- 00:01:14.866 provided in the appendix to our presentation, which is posted to our IR ...